Literature DB >> 10562558

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

M Gostissa1, A Hengstermann, V Fogal, P Sandy, S E Schwarz, M Scheffner, G Del Sal.   

Abstract

The growth-suppressive properties of p53 are controlled by posttranslational modifications and by regulation of its turnover rate. Here we show that p53 can be modified in vitro and in vivo by conjugation to the small ubiquitin-like protein SUMO-1. A lysine residue at amino acid position 386 of p53 is required for this previously undescribed modification, strongly suggesting that this lysine residue serves as the major attachment site for SUMO-1. Unlike ubiquitin, attachment of SUMO-1 does not appear to target proteins for rapid degradation but rather, has been proposed to change the ability of the modified protein to interact with other cellular proteins. Accordingly, we provide evidence that conjugation of SUMO-1 to wild-type p53 results in an increased transactivation ability of p53. We suggest that posttranslational modification of p53 by SUMO-1 conjugation provides a novel mechanism to regulate p53 activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562558      PMCID: PMC1171709          DOI: 10.1093/emboj/18.22.6462

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  138 in total

1.  The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1.

Authors:  M Furukawa; Y Zhang; J McCarville; T Ohta; Y Xiong
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.

Authors:  Darja Schmidt; Stefan Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis.

Authors:  R Benetti; G Del Sal; M Monte; G Paroni; C Brancolini; C Schneider
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

6.  UBC9 autosumoylation negatively regulates sumoylation of septins in Saccharomyces cerevisiae.

Authors:  Chia-Wen Ho; Hung-Ta Chen; Jaulang Hwang
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

7.  Histone sumoylation is associated with transcriptional repression.

Authors:  Yuzuru Shiio; Robert N Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

8.  Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53.

Authors:  Xian Zhang; Roger J A Grand; Christopher J McCabe; Jayne A Franklyn; Phillip H Gallimore; Andrew S Turnell
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.

Authors:  Eliana Munarriz; Daniela Barcaroli; Anastasis Stephanou; Paul A Townsend; Carine Maisse; Alessandro Terrinoni; Michael H Neale; Seamus J Martin; David S Latchman; Richard A Knight; Gerry Melino; Vincenzo De Laurenzi
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.